nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—CYP2C19—Esomeprazole—Barrett's esophagus	0.289	0.481	CbGbCtD
Gliclazide—CYP2C19—Omeprazole—Barrett's esophagus	0.17	0.283	CbGbCtD
Gliclazide—CYP2C9—Omeprazole—Barrett's esophagus	0.141	0.236	CbGbCtD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00961	0.156	CbGpPWpGaD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00932	0.151	CbGpPWpGaD
Gliclazide—Glipizide—PPARG—Barrett's esophagus	0.00373	1	CrCbGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0031	0.0502	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00235	0.038	CbGpPWpGaD
Gliclazide—VEGFA—Heart Development—BMP4—Barrett's esophagus	0.00225	0.0365	CbGpPWpGaD
Gliclazide—Glycosuria—Esomeprazole—Barrett's esophagus	0.00219	0.00656	CcSEcCtD
Gliclazide—Glycosuria—Omeprazole—Barrett's esophagus	0.00219	0.00656	CcSEcCtD
Gliclazide—VEGFA—Differentiation Pathway—BMP4—Barrett's esophagus	0.0021	0.034	CbGpPWpGaD
Gliclazide—Aggression—Omeprazole—Barrett's esophagus	0.00202	0.00605	CcSEcCtD
Gliclazide—Aggression—Esomeprazole—Barrett's esophagus	0.00202	0.00605	CcSEcCtD
Gliclazide—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00197	0.00589	CcSEcCtD
Gliclazide—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00197	0.00589	CcSEcCtD
Gliclazide—Arthropathy—Esomeprazole—Barrett's esophagus	0.00195	0.00585	CcSEcCtD
Gliclazide—Arthropathy—Omeprazole—Barrett's esophagus	0.00195	0.00585	CcSEcCtD
Gliclazide—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00188	0.00562	CcSEcCtD
Gliclazide—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00188	0.00562	CcSEcCtD
Gliclazide—Vaginal inflammation—Omeprazole—Barrett's esophagus	0.00178	0.00532	CcSEcCtD
Gliclazide—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00178	0.00532	CcSEcCtD
Gliclazide—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00178	0.00532	CcSEcCtD
Gliclazide—Vaginal inflammation—Esomeprazole—Barrett's esophagus	0.00178	0.00532	CcSEcCtD
Gliclazide—Melaena—Esomeprazole—Barrett's esophagus	0.00174	0.00519	CcSEcCtD
Gliclazide—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.00174	0.00519	CcSEcCtD
Gliclazide—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.00174	0.00519	CcSEcCtD
Gliclazide—Melaena—Omeprazole—Barrett's esophagus	0.00174	0.00519	CcSEcCtD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.00173	0.028	CbGpPWpGaD
Gliclazide—Cystitis—Omeprazole—Barrett's esophagus	0.00172	0.00513	CcSEcCtD
Gliclazide—Cystitis—Esomeprazole—Barrett's esophagus	0.00172	0.00513	CcSEcCtD
Gliclazide—Vaginal infection—Esomeprazole—Barrett's esophagus	0.00168	0.00502	CcSEcCtD
Gliclazide—Vaginal infection—Omeprazole—Barrett's esophagus	0.00168	0.00502	CcSEcCtD
Gliclazide—Oesophagitis—Omeprazole—Barrett's esophagus	0.00162	0.00486	CcSEcCtD
Gliclazide—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00162	0.00486	CcSEcCtD
Gliclazide—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00161	0.00483	CcSEcCtD
Gliclazide—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00161	0.00483	CcSEcCtD
Gliclazide—Urine output increased—Omeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Neoplasm—Omeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Bladder pain—Omeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Urine output increased—Esomeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Neoplasm—Esomeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Bladder pain—Esomeprazole—Barrett's esophagus	0.00161	0.00481	CcSEcCtD
Gliclazide—Abnormal vision—Omeprazole—Barrett's esophagus	0.00155	0.00464	CcSEcCtD
Gliclazide—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00155	0.00464	CcSEcCtD
Gliclazide—VEGFA—S1P1 pathway—PTGS2—Barrett's esophagus	0.00151	0.0244	CbGpPWpGaD
Gliclazide—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00149	0.00446	CcSEcCtD
Gliclazide—Sleep disorder—Omeprazole—Barrett's esophagus	0.00149	0.00446	CcSEcCtD
Gliclazide—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00148	0.00444	CcSEcCtD
Gliclazide—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00148	0.00444	CcSEcCtD
Gliclazide—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00148	0.00442	CcSEcCtD
Gliclazide—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00148	0.00442	CcSEcCtD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—HGF—Barrett's esophagus	0.00147	0.0238	CbGpPWpGaD
Gliclazide—Polyuria—Omeprazole—Barrett's esophagus	0.00147	0.00439	CcSEcCtD
Gliclazide—Photosensitivity—Omeprazole—Barrett's esophagus	0.00147	0.00439	CcSEcCtD
Gliclazide—Polyuria—Esomeprazole—Barrett's esophagus	0.00147	0.00439	CcSEcCtD
Gliclazide—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00147	0.00439	CcSEcCtD
Gliclazide—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00146	0.00435	CcSEcCtD
Gliclazide—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00146	0.00435	CcSEcCtD
Gliclazide—Hepatic failure—Omeprazole—Barrett's esophagus	0.00144	0.00429	CcSEcCtD
Gliclazide—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00144	0.00429	CcSEcCtD
Gliclazide—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00143	0.00427	CcSEcCtD
Gliclazide—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00143	0.00427	CcSEcCtD
Gliclazide—Injury—Omeprazole—Barrett's esophagus	0.0014	0.0042	CcSEcCtD
Gliclazide—Injury—Esomeprazole—Barrett's esophagus	0.0014	0.0042	CcSEcCtD
Gliclazide—Increased appetite—Omeprazole—Barrett's esophagus	0.00137	0.00411	CcSEcCtD
Gliclazide—Increased appetite—Esomeprazole—Barrett's esophagus	0.00137	0.00411	CcSEcCtD
Gliclazide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00136	0.00407	CcSEcCtD
Gliclazide—Visual disturbance—Omeprazole—Barrett's esophagus	0.00136	0.00407	CcSEcCtD
Gliclazide—Thirst—Esomeprazole—Barrett's esophagus	0.00136	0.00405	CcSEcCtD
Gliclazide—Renal impairment—Omeprazole—Barrett's esophagus	0.00136	0.00405	CcSEcCtD
Gliclazide—Thirst—Omeprazole—Barrett's esophagus	0.00136	0.00405	CcSEcCtD
Gliclazide—Renal impairment—Esomeprazole—Barrett's esophagus	0.00136	0.00405	CcSEcCtD
Gliclazide—Arthritis—Esomeprazole—Barrett's esophagus	0.00133	0.00397	CcSEcCtD
Gliclazide—Arthritis—Omeprazole—Barrett's esophagus	0.00133	0.00397	CcSEcCtD
Gliclazide—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00132	0.00395	CcSEcCtD
Gliclazide—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00132	0.00395	CcSEcCtD
Gliclazide—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00129	0.00387	CcSEcCtD
Gliclazide—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00129	0.00387	CcSEcCtD
Gliclazide—Diplopia—Esomeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Pain in extremity—Omeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Diplopia—Omeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00129	0.00386	CcSEcCtD
Gliclazide—VEGFA—Differentiation Pathway—HGF—Barrett's esophagus	0.00127	0.0206	CbGpPWpGaD
Gliclazide—Dry skin—Esomeprazole—Barrett's esophagus	0.00118	0.00354	CcSEcCtD
Gliclazide—Dry skin—Omeprazole—Barrett's esophagus	0.00118	0.00354	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00116	0.00348	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00116	0.00348	CcSEcCtD
Gliclazide—Gastritis—Esomeprazole—Barrett's esophagus	0.00114	0.00342	CcSEcCtD
Gliclazide—Gastritis—Omeprazole—Barrett's esophagus	0.00114	0.00342	CcSEcCtD
Gliclazide—Abdominal distension—Omeprazole—Barrett's esophagus	0.00112	0.00336	CcSEcCtD
Gliclazide—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00112	0.00336	CcSEcCtD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00112	0.0182	CbGpPWpGaD
Gliclazide—Asthma—Esomeprazole—Barrett's esophagus	0.00111	0.00334	CcSEcCtD
Gliclazide—Asthma—Omeprazole—Barrett's esophagus	0.00111	0.00334	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—CDKN2A—Barrett's esophagus	0.00109	0.0176	CbGpPWpGaD
Gliclazide—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00109	0.00325	CcSEcCtD
Gliclazide—Angina pectoris—Omeprazole—Barrett's esophagus	0.00109	0.00325	CcSEcCtD
Gliclazide—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00106	0.00317	CcSEcCtD
Gliclazide—Pancytopenia—Omeprazole—Barrett's esophagus	0.00106	0.00317	CcSEcCtD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00106	0.0171	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00106	0.0171	CbGpPWpGaD
Gliclazide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00104	0.0031	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00104	0.0031	CcSEcCtD
Gliclazide—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00103	0.00307	CcSEcCtD
Gliclazide—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00103	0.00307	CcSEcCtD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00102	0.0166	CbGpPWpGaD
Gliclazide—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00102	0.00304	CcSEcCtD
Gliclazide—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00102	0.00304	CcSEcCtD
Gliclazide—Weight increased—Esomeprazole—Barrett's esophagus	0.00101	0.00304	CcSEcCtD
Gliclazide—Weight increased—Omeprazole—Barrett's esophagus	0.00101	0.00304	CcSEcCtD
Gliclazide—Depression—Esomeprazole—Barrett's esophagus	0.000991	0.00297	CcSEcCtD
Gliclazide—Depression—Omeprazole—Barrett's esophagus	0.000991	0.00297	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—CXCL8—Barrett's esophagus	0.000987	0.016	CbGpPWpGaD
Gliclazide—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000985	0.00295	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000985	0.00295	CcSEcCtD
Gliclazide—Renal failure—Esomeprazole—Barrett's esophagus	0.000977	0.00292	CcSEcCtD
Gliclazide—Renal failure—Omeprazole—Barrett's esophagus	0.000977	0.00292	CcSEcCtD
Gliclazide—Jaundice—Esomeprazole—Barrett's esophagus	0.000969	0.0029	CcSEcCtD
Gliclazide—Jaundice—Omeprazole—Barrett's esophagus	0.000969	0.0029	CcSEcCtD
Gliclazide—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000966	0.00289	CcSEcCtD
Gliclazide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000966	0.00289	CcSEcCtD
Gliclazide—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000966	0.00289	CcSEcCtD
Gliclazide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000966	0.00289	CcSEcCtD
Gliclazide—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00094	0.00281	CcSEcCtD
Gliclazide—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00094	0.00281	CcSEcCtD
Gliclazide—Epistaxis—Omeprazole—Barrett's esophagus	0.000938	0.0028	CcSEcCtD
Gliclazide—Epistaxis—Esomeprazole—Barrett's esophagus	0.000938	0.0028	CcSEcCtD
Gliclazide—Sinusitis—Esomeprazole—Barrett's esophagus	0.000933	0.00279	CcSEcCtD
Gliclazide—Sinusitis—Omeprazole—Barrett's esophagus	0.000933	0.00279	CcSEcCtD
Gliclazide—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000928	0.00278	CcSEcCtD
Gliclazide—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000928	0.00278	CcSEcCtD
Gliclazide—Bradycardia—Esomeprazole—Barrett's esophagus	0.000908	0.00272	CcSEcCtD
Gliclazide—Bradycardia—Omeprazole—Barrett's esophagus	0.000908	0.00272	CcSEcCtD
Gliclazide—Rhinitis—Omeprazole—Barrett's esophagus	0.000895	0.00268	CcSEcCtD
Gliclazide—Rhinitis—Esomeprazole—Barrett's esophagus	0.000895	0.00268	CcSEcCtD
Gliclazide—Hepatitis—Omeprazole—Barrett's esophagus	0.000892	0.00267	CcSEcCtD
Gliclazide—Hepatitis—Esomeprazole—Barrett's esophagus	0.000892	0.00267	CcSEcCtD
Gliclazide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000888	0.00266	CcSEcCtD
Gliclazide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000888	0.00266	CcSEcCtD
Gliclazide—Pharyngitis—Omeprazole—Barrett's esophagus	0.000886	0.00265	CcSEcCtD
Gliclazide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000886	0.00265	CcSEcCtD
Gliclazide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000879	0.00263	CcSEcCtD
Gliclazide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000879	0.00263	CcSEcCtD
Gliclazide—Visual impairment—Esomeprazole—Barrett's esophagus	0.00086	0.00257	CcSEcCtD
Gliclazide—Visual impairment—Omeprazole—Barrett's esophagus	0.00086	0.00257	CcSEcCtD
Gliclazide—VEGFA—Platelet degranulation—HGF—Barrett's esophagus	0.000846	0.0137	CbGpPWpGaD
Gliclazide—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000844	0.00252	CcSEcCtD
Gliclazide—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000844	0.00252	CcSEcCtD
Gliclazide—Eye disorder—Omeprazole—Barrett's esophagus	0.000834	0.00249	CcSEcCtD
Gliclazide—Eye disorder—Esomeprazole—Barrett's esophagus	0.000834	0.00249	CcSEcCtD
Gliclazide—Tinnitus—Omeprazole—Barrett's esophagus	0.000832	0.00249	CcSEcCtD
Gliclazide—Tinnitus—Esomeprazole—Barrett's esophagus	0.000832	0.00249	CcSEcCtD
Gliclazide—Flushing—Esomeprazole—Barrett's esophagus	0.000828	0.00248	CcSEcCtD
Gliclazide—Flushing—Omeprazole—Barrett's esophagus	0.000828	0.00248	CcSEcCtD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000806	0.013	CbGpPWpGaD
Gliclazide—Chills—Esomeprazole—Barrett's esophagus	0.000801	0.0024	CcSEcCtD
Gliclazide—Chills—Omeprazole—Barrett's esophagus	0.000801	0.0024	CcSEcCtD
Gliclazide—Mental disorder—Esomeprazole—Barrett's esophagus	0.000782	0.00234	CcSEcCtD
Gliclazide—Mental disorder—Omeprazole—Barrett's esophagus	0.000782	0.00234	CcSEcCtD
Gliclazide—Malnutrition—Omeprazole—Barrett's esophagus	0.000777	0.00232	CcSEcCtD
Gliclazide—Malnutrition—Esomeprazole—Barrett's esophagus	0.000777	0.00232	CcSEcCtD
Gliclazide—Flatulence—Omeprazole—Barrett's esophagus	0.000765	0.00229	CcSEcCtD
Gliclazide—Flatulence—Esomeprazole—Barrett's esophagus	0.000765	0.00229	CcSEcCtD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000764	0.0124	CbGpPWpGaD
Gliclazide—Tension—Esomeprazole—Barrett's esophagus	0.000762	0.00228	CcSEcCtD
Gliclazide—Tension—Omeprazole—Barrett's esophagus	0.000762	0.00228	CcSEcCtD
Gliclazide—Nervousness—Esomeprazole—Barrett's esophagus	0.000754	0.00226	CcSEcCtD
Gliclazide—Nervousness—Omeprazole—Barrett's esophagus	0.000754	0.00226	CcSEcCtD
Gliclazide—Back pain—Omeprazole—Barrett's esophagus	0.000751	0.00225	CcSEcCtD
Gliclazide—Back pain—Esomeprazole—Barrett's esophagus	0.000751	0.00225	CcSEcCtD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000742	0.012	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000735	0.0119	CbGpPWpGaD
Gliclazide—Tremor—Omeprazole—Barrett's esophagus	0.000728	0.00218	CcSEcCtD
Gliclazide—Tremor—Esomeprazole—Barrett's esophagus	0.000728	0.00218	CcSEcCtD
Gliclazide—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000725	0.0117	CbGpPWpGaD
Gliclazide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000721	0.00216	CcSEcCtD
Gliclazide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000721	0.00216	CcSEcCtD
Gliclazide—Anaemia—Omeprazole—Barrett's esophagus	0.000718	0.00215	CcSEcCtD
Gliclazide—Anaemia—Esomeprazole—Barrett's esophagus	0.000718	0.00215	CcSEcCtD
Gliclazide—Agitation—Omeprazole—Barrett's esophagus	0.000714	0.00214	CcSEcCtD
Gliclazide—Agitation—Esomeprazole—Barrett's esophagus	0.000714	0.00214	CcSEcCtD
Gliclazide—Angioedema—Omeprazole—Barrett's esophagus	0.00071	0.00212	CcSEcCtD
Gliclazide—Angioedema—Esomeprazole—Barrett's esophagus	0.00071	0.00212	CcSEcCtD
Gliclazide—Malaise—Esomeprazole—Barrett's esophagus	0.0007	0.0021	CcSEcCtD
Gliclazide—Malaise—Omeprazole—Barrett's esophagus	0.0007	0.0021	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000696	0.0113	CbGpPWpGaD
Gliclazide—Leukopenia—Esomeprazole—Barrett's esophagus	0.000695	0.00208	CcSEcCtD
Gliclazide—Leukopenia—Omeprazole—Barrett's esophagus	0.000695	0.00208	CcSEcCtD
Gliclazide—Palpitations—Omeprazole—Barrett's esophagus	0.000686	0.00205	CcSEcCtD
Gliclazide—Palpitations—Esomeprazole—Barrett's esophagus	0.000686	0.00205	CcSEcCtD
Gliclazide—Cough—Esomeprazole—Barrett's esophagus	0.000678	0.00203	CcSEcCtD
Gliclazide—Cough—Omeprazole—Barrett's esophagus	0.000678	0.00203	CcSEcCtD
Gliclazide—Hypertension—Omeprazole—Barrett's esophagus	0.000671	0.00201	CcSEcCtD
Gliclazide—Hypertension—Esomeprazole—Barrett's esophagus	0.000671	0.00201	CcSEcCtD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00067	0.0108	CbGpPWpGaD
Gliclazide—Arthralgia—Esomeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—Myalgia—Esomeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—Chest pain—Omeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—Arthralgia—Omeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—Myalgia—Omeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—Chest pain—Esomeprazole—Barrett's esophagus	0.000661	0.00198	CcSEcCtD
Gliclazide—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000661	0.0107	CbGpPWpGaD
Gliclazide—Anxiety—Esomeprazole—Barrett's esophagus	0.000659	0.00197	CcSEcCtD
Gliclazide—Anxiety—Omeprazole—Barrett's esophagus	0.000659	0.00197	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000657	0.00196	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000657	0.00196	CcSEcCtD
Gliclazide—Discomfort—Omeprazole—Barrett's esophagus	0.000653	0.00195	CcSEcCtD
Gliclazide—Discomfort—Esomeprazole—Barrett's esophagus	0.000653	0.00195	CcSEcCtD
Gliclazide—Dry mouth—Esomeprazole—Barrett's esophagus	0.000647	0.00193	CcSEcCtD
Gliclazide—Dry mouth—Omeprazole—Barrett's esophagus	0.000647	0.00193	CcSEcCtD
Gliclazide—Confusional state—Omeprazole—Barrett's esophagus	0.000639	0.00191	CcSEcCtD
Gliclazide—Confusional state—Esomeprazole—Barrett's esophagus	0.000639	0.00191	CcSEcCtD
Gliclazide—Infection—Omeprazole—Barrett's esophagus	0.00063	0.00188	CcSEcCtD
Gliclazide—Infection—Esomeprazole—Barrett's esophagus	0.00063	0.00188	CcSEcCtD
Gliclazide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000622	0.00186	CcSEcCtD
Gliclazide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000622	0.00186	CcSEcCtD
Gliclazide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000621	0.00186	CcSEcCtD
Gliclazide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000621	0.00186	CcSEcCtD
Gliclazide—Tachycardia—Esomeprazole—Barrett's esophagus	0.000619	0.00185	CcSEcCtD
Gliclazide—Tachycardia—Omeprazole—Barrett's esophagus	0.000619	0.00185	CcSEcCtD
Gliclazide—Skin disorder—Esomeprazole—Barrett's esophagus	0.000616	0.00184	CcSEcCtD
Gliclazide—Skin disorder—Omeprazole—Barrett's esophagus	0.000616	0.00184	CcSEcCtD
Gliclazide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000613	0.00183	CcSEcCtD
Gliclazide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000613	0.00183	CcSEcCtD
Gliclazide—VEGFA—Bladder Cancer—TP53—Barrett's esophagus	0.000606	0.00981	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000596	0.00964	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000579	0.00938	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000578	0.00173	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000578	0.00173	CcSEcCtD
Gliclazide—Insomnia—Omeprazole—Barrett's esophagus	0.000573	0.00172	CcSEcCtD
Gliclazide—Insomnia—Esomeprazole—Barrett's esophagus	0.000573	0.00172	CcSEcCtD
Gliclazide—Paraesthesia—Omeprazole—Barrett's esophagus	0.000569	0.0017	CcSEcCtD
Gliclazide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000569	0.0017	CcSEcCtD
Gliclazide—Dyspnoea—Omeprazole—Barrett's esophagus	0.000565	0.00169	CcSEcCtD
Gliclazide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000565	0.00169	CcSEcCtD
Gliclazide—Somnolence—Omeprazole—Barrett's esophagus	0.000564	0.00169	CcSEcCtD
Gliclazide—Somnolence—Esomeprazole—Barrett's esophagus	0.000564	0.00169	CcSEcCtD
Gliclazide—Dyspepsia—Omeprazole—Barrett's esophagus	0.000558	0.00167	CcSEcCtD
Gliclazide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000558	0.00167	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000547	0.00164	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000547	0.00164	CcSEcCtD
Gliclazide—Fatigue—Omeprazole—Barrett's esophagus	0.000547	0.00164	CcSEcCtD
Gliclazide—Fatigue—Esomeprazole—Barrett's esophagus	0.000547	0.00164	CcSEcCtD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000543	0.00879	CbGpPWpGaD
Gliclazide—Pain—Esomeprazole—Barrett's esophagus	0.000542	0.00162	CcSEcCtD
Gliclazide—Constipation—Esomeprazole—Barrett's esophagus	0.000542	0.00162	CcSEcCtD
Gliclazide—Pain—Omeprazole—Barrett's esophagus	0.000542	0.00162	CcSEcCtD
Gliclazide—Constipation—Omeprazole—Barrett's esophagus	0.000542	0.00162	CcSEcCtD
Gliclazide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000522	0.00156	CcSEcCtD
Gliclazide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000522	0.00156	CcSEcCtD
Gliclazide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000518	0.00155	CcSEcCtD
Gliclazide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000518	0.00155	CcSEcCtD
Gliclazide—Urticaria—Esomeprazole—Barrett's esophagus	0.000504	0.00151	CcSEcCtD
Gliclazide—Urticaria—Omeprazole—Barrett's esophagus	0.000504	0.00151	CcSEcCtD
Gliclazide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000501	0.0015	CcSEcCtD
Gliclazide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000501	0.0015	CcSEcCtD
Gliclazide—Body temperature increased—Omeprazole—Barrett's esophagus	0.000501	0.0015	CcSEcCtD
Gliclazide—Abdominal pain—Omeprazole—Barrett's esophagus	0.000501	0.0015	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000469	0.0076	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CXCL8—Barrett's esophagus	0.000467	0.00756	CbGpPWpGaD
Gliclazide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000467	0.0014	CcSEcCtD
Gliclazide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000467	0.0014	CcSEcCtD
Gliclazide—Asthenia—Omeprazole—Barrett's esophagus	0.000455	0.00136	CcSEcCtD
Gliclazide—Asthenia—Esomeprazole—Barrett's esophagus	0.000455	0.00136	CcSEcCtD
Gliclazide—Pruritus—Omeprazole—Barrett's esophagus	0.000449	0.00134	CcSEcCtD
Gliclazide—Pruritus—Esomeprazole—Barrett's esophagus	0.000449	0.00134	CcSEcCtD
Gliclazide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000434	0.0013	CcSEcCtD
Gliclazide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000434	0.0013	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—HGF—Barrett's esophagus	0.000423	0.00685	CbGpPWpGaD
Gliclazide—Dizziness—Omeprazole—Barrett's esophagus	0.000419	0.00125	CcSEcCtD
Gliclazide—Dizziness—Esomeprazole—Barrett's esophagus	0.000419	0.00125	CcSEcCtD
Gliclazide—Vomiting—Omeprazole—Barrett's esophagus	0.000403	0.00121	CcSEcCtD
Gliclazide—Vomiting—Esomeprazole—Barrett's esophagus	0.000403	0.00121	CcSEcCtD
Gliclazide—Rash—Esomeprazole—Barrett's esophagus	0.0004	0.0012	CcSEcCtD
Gliclazide—Rash—Omeprazole—Barrett's esophagus	0.0004	0.0012	CcSEcCtD
Gliclazide—Dermatitis—Omeprazole—Barrett's esophagus	0.000399	0.00119	CcSEcCtD
Gliclazide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000399	0.00119	CcSEcCtD
Gliclazide—Headache—Omeprazole—Barrett's esophagus	0.000397	0.00119	CcSEcCtD
Gliclazide—Headache—Esomeprazole—Barrett's esophagus	0.000397	0.00119	CcSEcCtD
Gliclazide—Nausea—Esomeprazole—Barrett's esophagus	0.000377	0.00113	CcSEcCtD
Gliclazide—Nausea—Omeprazole—Barrett's esophagus	0.000377	0.00113	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000375	0.00607	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000347	0.00562	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000335	0.00542	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000316	0.00512	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000313	0.00507	CbGpPWpGaD
Gliclazide—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000312	0.00505	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000299	0.00483	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000288	0.00467	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000288	0.00466	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000285	0.0046	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000284	0.0046	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000271	0.00439	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000248	0.00402	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGES—Barrett's esophagus	0.000247	0.00399	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGES—Barrett's esophagus	0.000239	0.00387	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000238	0.00385	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00022	0.00356	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000202	0.00327	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000201	0.00325	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2A—Barrett's esophagus	0.000196	0.00318	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HGF—Barrett's esophagus	0.000193	0.00313	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—RELA—Barrett's esophagus	0.000189	0.00306	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP26A1—Barrett's esophagus	0.000187	0.00303	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000183	0.00295	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP26A1—Barrett's esophagus	0.000181	0.00293	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000179	0.00289	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CXCL8—Barrett's esophagus	0.000178	0.00288	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000171	0.00276	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00016	0.0026	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00016	0.00259	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000156	0.00252	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000151	0.00245	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000146	0.00237	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000141	0.00229	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—PPARG—Barrett's esophagus	0.000141	0.00229	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC9A1—Barrett's esophagus	0.000135	0.00218	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GAST—Barrett's esophagus	0.000134	0.00217	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000132	0.00214	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC9A1—Barrett's esophagus	0.000131	0.00211	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—Barrett's esophagus	0.000117	0.00189	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—RELA—Barrett's esophagus	0.000114	0.00185	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—Barrett's esophagus	0.000109	0.00177	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	9.28e-05	0.0015	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SST—Barrett's esophagus	9.2e-05	0.00149	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGES—Barrett's esophagus	7.95e-05	0.00129	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGES—Barrett's esophagus	7.14e-05	0.00116	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HGF—Barrett's esophagus	6.83e-05	0.0011	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	6.51e-05	0.00105	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—Barrett's esophagus	6.49e-05	0.00105	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—Barrett's esophagus	6.15e-05	0.000996	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP26A1—Barrett's esophagus	6.03e-05	0.000976	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—Barrett's esophagus	5.96e-05	0.000965	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	5.41e-05	0.000876	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	4.93e-05	0.000798	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APC—Barrett's esophagus	4.87e-05	0.000788	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—Barrett's esophagus	4.84e-05	0.000783	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—Barrett's esophagus	4.69e-05	0.000759	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.45e-05	0.000721	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC9A1—Barrett's esophagus	4.34e-05	0.000703	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4e-05	0.000647	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	3.9e-05	0.000631	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—Barrett's esophagus	3.8e-05	0.000616	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.65e-05	0.00059	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—Barrett's esophagus	3.59e-05	0.00058	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	3.56e-05	0.000576	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.5e-05	0.000567	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.14e-05	0.000509	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.87e-05	0.000464	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—Barrett's esophagus	2.29e-05	0.000371	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—Barrett's esophagus	2.2e-05	0.000356	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—Barrett's esophagus	1.98e-05	0.000321	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—Barrett's esophagus	1.78e-05	0.000288	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	1.62e-05	0.000263	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—Barrett's esophagus	1.56e-05	0.000253	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	1.4e-05	0.000227	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	1.28e-05	0.000207	CbGpPWpGaD
